Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.


Journal

Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R

Informations de publication

Date de publication:
16 04 2021
Historique:
received: 30 09 2020
revised: 06 01 2021
accepted: 05 02 2021
pubmed: 22 2 2021
medline: 23 6 2021
entrez: 21 2 2021
Statut: ppublish

Résumé

Alpha-synuclein (α-syn) fibrils, a major constituent of the neurotoxic Lewy Bodies in Parkinson's disease, form via nucleation dependent polymerization and can replicate by a seeding mechanism. Brazilin, a small molecule derived from red cedarwood trees in Brazil, has been shown to inhibit the fibrillogenesis of amyloid-beta (Aβ) and α-syn as well as remodel mature fibrils and reduce cytotoxicity. Here we test the effects of Brazilin on both seeded and unseeded α-syn fibril formation and show that the natural polyphenol inhibits fibrillogenesis of α-syn by a unique mechanism that alters conformational equilibria in two separate points of the assembly mechanism: Brazilin preserves the natively unfolded state of α-syn by specifically binding to the compact conformation of the α-syn monomer. Brazilin also eliminates seeding competence of α-syn assemblies from Parkinson's disease patient brain tissue, and reduces toxicity of pre-formed assemblies in primary neurons by inducing the formation of large fibril clusters. Molecular docking of Brazilin shows the molecule to interact both with unfolded α-syn monomers and with the cross-β sheet structure of α-syn fibrils. Our findings suggest that Brazilin has substantial potential as a neuroprotective and therapeutic agent for Parkinson's disease.

Identifiants

pubmed: 33610557
pii: S0022-2836(21)00072-3
doi: 10.1016/j.jmb.2021.166878
pmc: PMC7610480
mid: EMS119961
pii:
doi:

Substances chimiques

Amyloid 0
Amyloid beta-Peptides 0
Benzopyrans 0
alpha-Synuclein 0
brazilin FZ39SW1K10

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

166878

Subventions

Organisme : Wellcome Trust
ID : 208385
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/E012558/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1604/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204963
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1004/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M02492X/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204963/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/6
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R21 NS101588
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00024/2
Pays : United Kingdom

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Biochemistry. 2000 Mar 14;39(10):2552-63
pubmed: 10704204
J Biol Chem. 2016 Sep 9;291(37):19590-606
pubmed: 27458018
FEBS J. 2007 Aug;274(15):3766-74
pubmed: 17617226
Chem Commun (Camb). 2018 Aug 2;54(63):8667-8684
pubmed: 29978862
Nat Chem Biol. 2009 Jan;5(1):15-22
pubmed: 19088715
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7710-5
pubmed: 20385841
Science. 2001 Nov 9;294(5545):1346-9
pubmed: 11701929
Proteins. 2001 May 1;43(2):186-202
pubmed: 11276088
Brain. 2016 Feb;139(Pt 2):481-94
pubmed: 26647156
Methods Mol Biol. 2019;1873:19-37
pubmed: 30341601
Sci Adv. 2019 Apr 17;5(4):eaau3112
pubmed: 31001578
Annu Rev Biochem. 1997;66:385-407
pubmed: 9242912
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
J Biol Chem. 2010 Jul 30;285(31):24228-37
pubmed: 20511235
Sci Rep. 2015 Jan 23;5:7992
pubmed: 25613018
Phys Chem Chem Phys. 2015 Apr 7;17(13):8338-48
pubmed: 25406896
J Ethnopharmacol. 2014;151(1):108-13
pubmed: 24095700
J Biol Chem. 2002 Jan 18;277(3):1641-4
pubmed: 11707429
J Am Soc Mass Spectrom. 2013 Sep;24(9):1346-54
pubmed: 23817832
Biochemistry. 2009 Sep 8;48(35):8322-34
pubmed: 19645507
Biochim Biophys Acta. 2012 Feb;1822(2):261-85
pubmed: 22024360
Int J High Perform Comput Appl. 2015 May;29(2):119-134
pubmed: 25972727
Nat Commun. 2018 Jul 11;9(1):2676
pubmed: 29992960
Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8637-42
pubmed: 18550842
Biochemistry. 2005 Apr 5;44(13):4977-83
pubmed: 15794636
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
pubmed: 9811807
Nat Struct Mol Biol. 2008 Jun;15(6):558-66
pubmed: 18511942
Biomolecules. 2015 Mar 25;5(2):282-305
pubmed: 25816357
Biomed Chromatogr. 2013 Jun;27(6):802-6
pubmed: 23303567
Neuropathol Appl Neurobiol. 2016 Feb;42(1):51-76
pubmed: 26666838
J Biol Chem. 2001 Nov 23;276(47):44284-96
pubmed: 11553618
Biochemistry. 2008 Apr 22;47(16):4651-6
pubmed: 18366183
Proteins. 2009 Dec;77(4):778-95
pubmed: 19603484
Biochim Biophys Acta. 2016 Sep;1864(9):1160-1169
pubmed: 27353564
Nat Chem Biol. 2011 Nov 20;8(1):93-101
pubmed: 22101602
Anal Chem. 2016 Sep 6;88(17):8468-75
pubmed: 27467405
Chem Biol Drug Des. 2006 Jan;67(1):27-37
pubmed: 16492146
J Mol Biol. 2002 Sep 13;322(2):383-93
pubmed: 12217698
J Biol Chem. 2007 Apr 6;282(14):10311-24
pubmed: 17284452
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jul 15;931:61-7
pubmed: 23777611
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16835-16840
pubmed: 31371504
FEBS Lett. 2011 Apr 20;585(8):1113-20
pubmed: 21443877
Science. 2010 Sep 24;329(5999):1663-7
pubmed: 20798282
FEBS Lett. 2015 Jan 2;589(1):77-83
pubmed: 25436420
Brain. 2015 Jun;138(Pt 6):1642-57
pubmed: 25732184
Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12207-11
pubmed: 15297610
Methods Enzymol. 1999;309:274-84
pubmed: 10507030
Biochemistry. 2016 Feb 2;55(4):675-85
pubmed: 26799377
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6
pubmed: 10639120
Nat Rev Mol Cell Biol. 2010 Apr;11(4):301-7
pubmed: 20308987
Proteins. 2011 Feb;79(2):611-21
pubmed: 21120859
J Chem Phys. 2015 Dec 28;143(24):243142
pubmed: 26723627
J Agric Food Chem. 2019 Oct 23;67(42):11769-11777
pubmed: 31575115
Nat Med. 1998 Nov;4(11):1318-20
pubmed: 9809558
J Neurochem. 2010 Jul;114(2):419-29
pubmed: 20412383
Protein Sci. 2012 Jul;21(7):911-7
pubmed: 22573613
Neurotherapeutics. 2013 Jul;10(3):429-39
pubmed: 23670234
Nat Commun. 2020 Jun 4;11(1):2820
pubmed: 32499486
Cell Chem Biol. 2018 Nov 15;25(11):1389-1402.e9
pubmed: 30197194
Biochemistry. 2012 Jan 10;51(1):126-37
pubmed: 22133042
Acta Neuropathol Commun. 2018 Feb 9;6(1):7
pubmed: 29422107
Sci Rep. 2015 Mar 18;5:9228
pubmed: 25784353
Neurosci Lett. 2007 Sep 7;424(2):78-82
pubmed: 17714865
Biochemistry. 2006 May 16;45(19):6085-94
pubmed: 16681381
Nature. 2002 Jul 18;418(6895):291
pubmed: 12124613
Sci Rep. 2018 Jul 23;8(1):11066
pubmed: 30038334
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171

Auteurs

George R Nahass (GR)

Colorado College, Colorado Springs, CO, USA; Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK; Washington University in St. Louis, St Louis, MO, USA; Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA.

Yuanzi Sun (Y)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.

Yong Xu (Y)

Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

Mark Batchelor (M)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.

Madeleine Reilly (M)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.

Iryna Benilova (I)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.

Niraja Kedia (N)

Washington University in St. Louis, St Louis, MO, USA.

Kevin Spehar (K)

Washington University in St. Louis, St Louis, MO, USA.

Frank Sobott (F)

Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

Richard B Sessions (RB)

Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.

Byron Caughey (B)

Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA.

Sheena E Radford (SE)

Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

Parmjit S Jat (PS)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.

John Collinge (J)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.

Jan Bieschke (J)

Medical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK; Washington University in St. Louis, St Louis, MO, USA. Electronic address: j.bieschke@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH